Heron Therapeutics Stock (NASDAQ:HRTX), Quotes and News Summary

Q: What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 2.324M
Day Range	- - -
52 Wk Range	0.500 - 3.220
Market Cap	$424.676M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	21.87%
Days to Cover	18.57

Recent News

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?

Heron Therapeutics' Q4 2023 results: Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in acute and oncology care franchises. Fiscal year 2024 guidance: $138 million-$158 million revenue, with positive adjusted EBITDA.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Heron Therapeutics (HRTX) stock?

You can purchase shares of Heron Therapeutics (NASDAQ: HRTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Heron Therapeutics's (HRTX) competitors?

Other companies in Heron Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL) and Anika Therapeutics (NASDAQ:ANIK).

What is the target price for Heron Therapeutics (HRTX) stock?

The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 5.00 expecting HRTX to rise to within 12 months (a possible 77.37% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Heron Therapeutics (HRTX)?

The stock price for Heron Therapeutics (NASDAQ: HRTX) is $2.8189 last updated May 14, 2024 at 6:28 PM EDT.

Does Heron Therapeutics (HRTX) pay a dividend?

There are no upcoming dividends for Heron Therapeutics.

When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?

Heron Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is Heron Therapeutics (HRTX) going to split?

There is no upcoming split for Heron Therapeutics.

What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-